WallStSmart

Novo Nordisk A/S (NVO)vsPure Storage Inc (PSTG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Novo Nordisk A/S generates 8338% more annual revenue ($309.06B vs $3.66B). NVO leads profitability with a 33.1% profit margin vs 5.1%. PSTG appears more attractively valued with a PEG of 1.47. PSTG earns a higher WallStSmart Score of 59/100 (C).

NVO

Buy

55

out of 100

Grade: C

Growth: 4.0Profit: 10.0Value: 4.7Quality: 4.8
Piotroski: 3/9Altman Z: 2.08

PSTG

Buy

59

out of 100

Grade: C

Growth: 8.0Profit: 5.0Value: 4.7Quality: 5.3
Piotroski: 4/9Altman Z: 1.22
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NVOSignificantly Overvalued (-60.8%)

Margin of Safety

-60.8%

Fair Value

$24.00

Current Price

$36.53

$12.53 premium

UndervaluedFair: $24.00Overvalued
PSTGSignificantly Overvalued (-195.4%)

Margin of Safety

-195.4%

Fair Value

$25.74

Current Price

$62.63

$36.89 premium

UndervaluedFair: $25.74Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NVO5 strengths · Avg: 9.8/10
P/E RatioValuation
10.3x10/10

Attractively priced relative to earnings

Return on EquityProfitability
60.7%10/10

Every $100 of equity generates 61 in profit

Profit MarginProfitability
33.1%10/10

Keeps 33 of every $100 in revenue as profit

Operating MarginProfitability
44.5%10/10

Strong operational efficiency at 44.5%

Market CapQuality
$162.84B9/10

Large-cap with strong market position

PSTG2 strengths · Avg: 9.0/10
EPS GrowthGrowth
140.6%10/10

Earnings expanding 140.6% YoY

Revenue GrowthGrowth
20.4%8/10

Revenue surging 20.4% year-over-year

Areas to Watch

NVO4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
4.882/10

Expensive relative to growth rate

Revenue GrowthGrowth
-7.6%2/10

Revenue declined 7.6%

EPS GrowthGrowth
-4.7%2/10

Earnings declined 4.7%

PSTG4 concerns · Avg: 2.8/10
Price/BookValuation
14.3x4/10

Trading at 14.3x book value

Profit MarginProfitability
5.1%3/10

5.1% margin — thin

P/E RatioValuation
113.9x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : NVO

The strongest argument for NVO centers on P/E Ratio, Return on Equity, Profit Margin. Profitability is solid with margins at 33.1% and operating margin at 44.5%.

Bull Case : PSTG

The strongest argument for PSTG centers on EPS Growth, Revenue Growth. Revenue growth of 20.4% demonstrates continued momentum. PEG of 1.47 suggests the stock is reasonably priced for its growth.

Bear Case : NVO

The primary concerns for NVO are Piotroski F-Score, PEG Ratio, Revenue Growth.

Bear Case : PSTG

The primary concerns for PSTG are Price/Book, Profit Margin, P/E Ratio. A P/E of 113.9x leaves little room for execution misses.

Key Dynamics to Monitor

NVO profiles as a declining stock while PSTG is a growth play — different risk/reward profiles.

PSTG carries more volatility with a beta of 1.33 — expect wider price swings.

PSTG is growing revenue faster at 20.4% — sustainability is the question.

PSTG generates stronger free cash flow (201M), providing more financial flexibility.

Bottom Line

PSTG scores higher overall (59/100 vs 55/100) and 20.4% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Novo Nordisk A/S

HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA

Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.

Pure Storage Inc

TECHNOLOGY · COMPUTER HARDWARE · USA

Pure Storage, Inc. provides data storage technology and solutions in the United States and internationally. The company is headquartered in Mountain View, California.

Want to dig deeper into these stocks?